ACADIA Pharmaceuticals
ACAD
#3635
Rank
C$4.91 B
Marketcap
C$28.83
Share price
-3.35%
Change (1 day)
17.20%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): C$0.19 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are C$1.07 Billion. a decrease over its 2024 earnings that were of C$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 C$0.19 B-46.18%
2024 C$0.35 B-605.67%
2023 -C$70.9 Million-76.09%
2022 -C$0.3 Billion27.41%
2021 -C$0.24 Billion-40.38%
2020 -C$0.4 Billion19.88%
2019 -C$0.33 Billion-3.92%
2018 -C$0.34 Billion-15.04%
2017 -C$0.4 Billion6.33%
2016 -C$0.38 Billion64.55%
2015 -C$0.23 Billion77.47%
2014 -C$0.13 Billion143.69%
2013 -C$52.72 Million81.93%
2012 -C$28.98 Million-8.73%
2011 -C$31.75 Million-251.39%
2010 C$20.96 M-133.2%
2009 -C$63.17 Million-30.82%
2008 -C$91.31 Million6.43%
2007 -C$85.8 Million25.89%
2006 -C$68.15 Million36.99%
2005 -C$49.75 Million37.22%
2004 -C$36.26 Million19.96%
2003 -C$30.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$46.61 B 24,054.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.15 B 7,237.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$35.74 B 18,424.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$12.95 B 6,615.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-C$0.17 Billion-187.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-C$53.67 Million-127.81%๐Ÿ‡บ๐Ÿ‡ธ USA